- Company Overview for DISRUPTYX THERAPEUTICS LIMITED (SC731650)
- Filing history for DISRUPTYX THERAPEUTICS LIMITED (SC731650)
- People for DISRUPTYX THERAPEUTICS LIMITED (SC731650)
- More for DISRUPTYX THERAPEUTICS LIMITED (SC731650)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
07 Jun 2024 | CS01 | Confirmation statement made on 5 May 2024 with no updates | |
07 Jun 2024 | AA | Accounts for a dormant company made up to 31 May 2024 | |
27 Oct 2023 | AA | Accounts for a dormant company made up to 31 May 2023 | |
21 Jun 2023 | CS01 | Confirmation statement made on 5 May 2023 with updates | |
20 Sep 2022 | PSC01 | Notification of Connor William Blair as a person with significant control on 12 September 2022 | |
20 Sep 2022 | PSC01 | Notification of George Scott Baillie as a person with significant control on 12 September 2022 | |
16 Sep 2022 | PSC04 | Change of details for Dr Douglas Fraser Gray as a person with significant control on 12 September 2022 | |
16 Sep 2022 | SH01 |
Statement of capital following an allotment of shares on 12 September 2022
|
|
19 May 2022 | CERTNM |
Company name changed disruptyve therapeutics LIMITED\certificate issued on 19/05/22
|
|
06 May 2022 | NEWINC |
Incorporation
Statement of capital on 2022-05-06
|